Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

SWX:NOVN
SWX:NOVNPharmaceuticals

Novartis Oncology Data Highlights Scemblix Momentum And Radioligand Growth Potential

Novartis (SWX:NOVN) reported long term clinical data for Scemblix showing sustained superior efficacy and a favorable safety profile in chronic myeloid leukemia. The company also released expanded clinical evidence for Pluvicto in prostate cancer, underscoring progress in its radioligand therapy franchise. These data come from pivotal clinical trials and mark important milestones for Novartis in hematology and oncology. For investors tracking large pharma, these updates touch two core...
LSE:DGE
LSE:DGEBeverage

Diageo Ready To Drink Pivot Under New CEO Puts Valuation In Focus

Diageo (LSE:DGE) has appointed Sir Dave Lewis as CEO, marking a change in leadership at the global spirits and beer company. The company is putting greater emphasis on ready-to-drink beverages, shifting attention toward this category as part of its broader business reset. This comes while Diageo is working through operational pressures, including significant debt and a dividend cut. Diageo, the owner of brands across spirits and beer, is now leaning more into the ready-to-drink segment...
IBSE:AKBNK
IBSE:AKBNKBanks

Top Middle Eastern Dividend Stocks To Consider In June 2026

Amidst the current geopolitical tensions and uncertainty over US-Iran peace talks, most Gulf markets have seen a downward trend, reflecting cautious investor sentiment. In such volatile times, dividend stocks can offer investors a measure of stability and income through regular payouts, making them an attractive option for those seeking to navigate the complexities of the Middle Eastern market.
NYSE:MH
NYSE:MHConsumer Services

A Look At McGraw Hill (MH) Valuation After A 25% Year To Date Share Price Decline

Recent performance snapshot McGraw Hill (MH) has drawn fresh attention after a period where the stock fell about 25% year to date, with a decline of roughly 13% over the past 3 months and a mixed shorter term return profile. See our latest analysis for McGraw Hill. The recent 1 month share price return of 4.1% contrasts with a weaker year to date share price return. This suggests any short term momentum is still working against a softer backdrop for McGraw Hill. If you are weighing what else...
NYSE:TAL
NYSE:TALConsumer Services

Assessing TAL Education Group’s Valuation After Recent Share Price Weakness

What recent performance tells you about TAL Education Group (NYSE:TAL) TAL Education Group (NYSE:TAL) has been back on many watchlists after a recent pullback, with the stock down about 11% over the past month and roughly 6% over the past 3 months. For context, the company reports revenue of US$3,008.9m and net income of US$530.8m, with both revenue and net income showing annual growth based on the latest figures available to investors. See our latest analysis for TAL Education Group. At the...
TSE:7240
TSE:7240Auto Components

A Look At NOK (TSE:7240) Valuation As Board Plans Leadership Changes And Director Elections

NOK (TSE:7240) has called a board meeting for May 20, 2026 to review changes in representative director roles, select new director candidates, and prepare for its June 25 shareholders meeting. See our latest analysis for NOK. Recent trading has been relatively firm, with a 1-day share price return of 0.68% and a 7-day share price return of 1.27%. The 1-year total shareholder return of 45.11% points to momentum that has built over time despite a softer 90-day share price return of 4.95%. If...
NasdaqGS:ONC
NasdaqGS:ONCBiotechs

BeOne Medicines ASCO Data Highlights Oncology Pipeline And Revenue Upside Potential

BeOne Medicines (NasdaqGS:ONC) presented new clinical data at the 2026 ASCO Annual Meeting on multiple oncology programs, including solid tumor candidates and bispecific antibodies. The company highlighted results for a CDK4 inhibitor in metastatic breast cancer, a B7-H4 targeting antibody drug conjugate in ovarian and breast cancers, and a bispecific antibody in hepatocellular carcinoma. BeOne also reported positive reimbursement progress in Canada for TEVIMBRA in nasopharyngeal carcinoma...
ENXTAM:HEIA
ENXTAM:HEIABeverage

Heineken Court Defeat Puts Greek Damages Risk And Valuation In Focus

Dutch Supreme Court rejects Heineken's final appeal in a competition damages case involving its Greek subsidiary, Athenian Brewery. The ruling clears the way for the Amsterdam District Court to assess a damages claim by Macedonian Thrace Brewery linked to past practices in Greece. The decision raises fresh questions for investors around potential financial and reputational effects for ENXTAM:HEIA. Heineken, listed as ENXTAM:HEIA, is one of the largest global brewers, with a broad portfolio...
NasdaqGM:WLDN
NasdaqGM:WLDNProfessional Services

Is It Too Late To Consider Willdan Group (WLDN) After Strong Multi Year Share Gains

If you are wondering whether Willdan Group at around US$95.72 is priced for future upside or already reflects high expectations, the current numbers raise some important questions about value. The stock has returned 2.7% over the past week and 29.4% over the last 30 days, while year to date it is down 10.3% and has returned 71.5% over 1 year and a very large 3 year gain, with a 5 year return of 143.4%. Recent headlines have focused on Willdan Group's role within professional services and its...
TSX:POW
TSX:POWInsurance

A Look At Power Corporation Of Canada’s Valuation As It Commits Capital To A New AI Fund

Why Power Corporation’s AI Fund Commitment Matters for Investors Power Corporation of Canada (TSX:POW) is drawing attention after the Power group committed a combined US$150 million to the newly created Sagard AI Fund LP. The fund targets AI adoption across financial services. This closed-end fund is set up to back AI-focused companies globally, while giving Power access to market intelligence, potential commercial partnerships, and practical pilots that could feed into its insurance, wealth,...
NYSE:UAA
NYSE:UAALuxury

Under Armour Ownership Raises Questions On Possible Go Private Value Upside

Under Armour (NYSE:UAA) is drawing attention as its founder-led structure and concentrated ownership raise the possibility of a friendly leveraged buyout that could take the company private. Founder Kevin Plank has returned as CEO, while investor Prem Watsa has built a significant stake, increasing insider and long-term investor influence over key decisions. The combination of a low valuation, ongoing restructuring efforts, and this ownership backdrop is feeding market speculation about a...
NYSE:ARE
NYSE:AREHealth Care REITs

Assessing Alexandria Real Estate Equities (ARE) Valuation After A Sharp Rebound In Share Price

Why Alexandria Real Estate Equities is on investors' radar today Alexandria Real Estate Equities (ARE) has drawn attention after recent share price moves, with the stock up about 8% over the past week and around 27% over the past month. That shift comes as investors weigh a market value of about US$8.5b against reported annual revenue of US$2.93b and a net loss of about US$1.07b, alongside mixed multi year total return figures. See our latest analysis for Alexandria Real Estate Equities. The...
NasdaqGS:ERIE
NasdaqGS:ERIEInsurance

Erie Indemnity Plans 2026 CFO Exit As Shares Continue To Slide

Erie Indemnity (NasdaqGS:ERIE) has announced that Executive Vice President and Chief Financial Officer Julie M. Pelkowski plans to retire at the end of 2026. The company now has a defined timeline to prepare for a CFO succession at a senior leadership level. For investors watching Erie Indemnity, this leadership change comes as the stock trades at $207.54 and has fallen 7% over the past week and 3.5% over the past month. The share price is also down 25.3% year to date and 41.6% over the...